CLINICAL RESEARCH: HEART FAILURE
Increased Central Venous Pressure Is Associated With Impaired Renal Function and Mortality in a Broad Spectrum of Patients With Cardiovascular Disease
Kevin Damman, MD*,
Vincent M. van Deursen*,
Gerjan Navis, MD, PhD ,
Adriaan A. Voors, MD, PhD*,
Dirk J. van Veldhuisen, MD, PhD, FACC* and
Hans L. Hillege, MD, PhD*, ,*
* Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
Department of Nephrology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
Manuscript received February 6, 2008;
revised manuscript received August 12, 2008,
accepted August 18, 2008.
* Reprint requests and correspondence to: Prof. Dr. Hans L. Hillege, Hanzeplein 1, 9700 RB Groningen, the Netherlands (Email: h.hillege{at}tcc.umcg.nl).
Objectives: We sought to investigate the relationship between increased central venous pressure (CVP), renal function, and mortality in a broad spectrum of cardiovascular patients.
Background: The pathophysiology of impaired renal function in cardiovascular disease is multifactorial. The relative importance of increased CVP has not been addressed previously.
Methods: A total of 2,557 patients who underwent right heart catheterization in the University Medical Center Groningen, the Netherlands, between January 1, 1989, and December 31, 2006, were identified, and their data were extracted from electronic databases. Estimated glomerular filtration rate (eGFR) was assessed with the simplified modification of diet in renal disease formula.
Results: Mean age was 59 ± 15 years, and 57% were men. Mean eGFR was 65 ± 24 ml/min/1.73 m2, with a cardiac index of 2.9 ± 0.8 l/min/m2 and CVP of 5.9 ± 4.3 mm Hg. We found that CVP was associated with cardiac index (r = –0.259, p < 0.0001) and eGFR (r = –0.147, p < 0.0001). Also, cardiac index was associated with eGFR (r = 0.123, p < 0.0001). In multivariate analysis CVP remained associated with eGFR (r = –0.108, p < 0.0001). In a median follow-up time of 10.7 years, 741 (29%) patients died. We found that CVP was an independent predictor of reduced survival (hazard ratio: 1.03 per mm Hg increase, 95% confidence interval: 1.01 to 1.05, p = 0.0032).
Conclusions: Increased CVP is associated with impaired renal function and independently related to all-cause mortality in a broad spectrum of patients with cardiovascular disease.
Key Words: renal function central venous pressure mortality prognosis heart catheterization
|
Abbreviations and Acronyms
| | CI = confidence interval | | CVP = central venous pressure | | eGFR = estimated glomerular filtration rate | | HR = hazard ratio |
|
Related Articles
-
The Cardiorenal Syndrome: Do We Need a Change of Strategy or a Change of Tactics?
- Mariell Jessup and Maria Rosa Costanzo
J. Am. Coll. Cardiol. 2009 53: 597-599.
[Full Text]
[PDF]
-
Inside This Issue
J. Am. Coll. Cardiol. 2009 53: A32.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
M. Metra, B. Davison, L. Bettari, H. Sun, C. Edwards, V. Lazzarini, B. Piovanelli, V. Carubelli, S. Bugatti, C. Lombardi, et al.
Is Worsening Renal Function an Ominous Prognostic Sign in Patients With Acute Heart Failure?: The Role of Congestion and Its Interaction With Renal Function
Circ Heart Fail,
January 1, 2012;
5(1):
54 - 62.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Takahashi, A. Takahashi, T. Kuwahara, K. Okubo, T. Fujino, K. Takagi, E. Nakashima, T. Kamiishi, H. Hikita, K. Hirao, et al.
Renal Function After Catheter Ablation of Atrial Fibrillation
Circulation,
November 29, 2011;
124(22):
2380 - 2387.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Mullens and W. H. W. Tang
The Early Intertwining of the Heart and the Kidney Through an Impaired Natriuretic Response to Acute Volume Expansion
J. Am. Coll. Cardiol.,
November 8, 2011;
58(20):
2104 - 2105.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Damman and C. M. O'Connor
Dangerous diuretics or death defying drugs?
Eur J Heart Fail,
November 1, 2011;
13(11):
1157 - 1158.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. G. Jungbauer, C. Birner, B. Jung, S. Buchner, M. Lubnow, C. von Bary, D. Endemann, B. Banas, M. Mack, C. A. Boger, et al.
Kidney injury molecule-1 and N-acetyl-ss-D-glucosaminidase in chronic heart failure: possible biomarkers of cardiorenal syndrome
Eur J Heart Fail,
October 1, 2011;
13(10):
1104 - 1110.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Testani, S. G. Coca, B. D. McCauley, R. P. Shannon, and S. E. Kimmel
Impact of changes in blood pressure during the treatment of acute decompensated heart failure on renal and clinical outcomes
Eur J Heart Fail,
August 1, 2011;
13(8):
877 - 884.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Guazzi, M. Vicenzi, R. Arena, and M. D. Guazzi
Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Target of Phosphodiesterase-5 Inhibition in a 1-Year Study
Circulation,
July 12, 2011;
124(2):
164 - 174.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Damman, M. J. Ng Kam Chuen, R. J. MacFadyen, G. Y. H. Lip, D. Gaze, P. O. Collinson, H. L. Hillege, W. van Oeveren, A. A. Voors, and D. J. van Veldhuisen
Volume Status and Diuretic Therapy in Systolic Heart Failure and the Detection of Early Abnormalities in Renal and Tubular Function
J. Am. Coll. Cardiol.,
May 31, 2011;
57(22):
2233 - 2241.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. Voors, H. C. Dittrich, B. M. Massie, P. DeLucca, G. A. Mansoor, M. Metra, G. Cotter, B. D. Weatherley, P. Ponikowski, J. R. Teerlink, et al.
Effects of the Adenosine A1 Receptor Antagonist Rolofylline on Renal Function in Patients With Acute Heart Failure and Renal Dysfunction: Results From PROTECT (Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function)
J. Am. Coll. Cardiol.,
May 10, 2011;
57(19):
1899 - 1907.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Uthoff, T. Breidthardt, T. Klima, M. Aschwanden, N. Arenja, T. Socrates, C. Heinisch, M. Noveanu, B. Frischknecht, U. Baumann, et al.
Central venous pressure and impaired renal function in patients with acute heart failure
Eur J Heart Fail,
April 1, 2011;
13(4):
432 - 439.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Van Bommel, S. A. Mollema, C. J. W. Borleffs, M. Bertini, C. Ypenburg, N. A. Marsan, V. Delgado, E. E. Van Der Wall, M. J. Schalij, and J. J. Bax
Impaired Renal Function Is Associated With Echocardiographic Nonresponse and Poor Prognosis After Cardiac Resynchronization Therapy
J. Am. Coll. Cardiol.,
February 1, 2011;
57(5):
549 - 555.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Metra, D. Brutsaert, L. Dei Cas, and M. Gheorghiade
Chapter 49 Acute heart failure: epidemiology, classification, and pathophysiology
The ESC Textbook of Acute and Intensive Cardiac Care,
December 1, 2010;
1(1):
med-9780199584314-chapter - med-9780199584314-chapter.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Damman, A. A. Voors, H. L. Hillege, G. Navis, P. Lechat, D. J. van Veldhuisen, H. J. Dargie, and for the CIBIS-2 Investigators and Committees
Congestion in chronic systolic heart failure is related to renal dysfunction and increased mortality
Eur J Heart Fail,
September 1, 2010;
12(9):
974 - 982.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Damman, D. J. Van Veldhuisen, G. Navis, V. S. Vaidya, T. D. J. Smilde, B. D. Westenbrink, J. V. Bonventre, A. A. Voors, and H. L. Hillege
Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate
Heart,
August 1, 2010;
96(16):
1297 - 1302.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. MacFadyen, M. J. Ng Kam Chuen, and R. C. Davis
Loop diuretic therapy in left ventricular systolic dysfunction: has familiarity bred contempt for a critical but potentially nephrotoxic cardio renal therapy?
Eur J Heart Fail,
July 1, 2010;
12(7):
649 - 652.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Bock and S. S. Gottlieb
Cardiorenal Syndrome: New Perspectives
Circulation,
June 15, 2010;
121(23):
2592 - 2600.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Uthoff, C. Thalhammer, M. Potocki, T. Reichlin, M. Noveanu, M. Aschwanden, D. Staub, N. Arenja, T. Socrates, R. Twerenbold, et al.
Central venous pressure at emergency room presentation predicts cardiac rehospitalization in patients with decompensated heart failure
Eur J Heart Fail,
May 1, 2010;
12(5):
469 - 476.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. Voors and D. J. van Veldhuisen
Cardiorenal Effects of Recombinant Human Natriuretic Peptides
J. Am. Coll. Cardiol.,
April 27, 2010;
55(17):
1852 - 1853.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. S. Pang, M. Komajda, and M. Gheorghiade
The current and future management of acute heart failure syndromes
Eur. Heart J.,
April 1, 2010;
31(7):
784 - 793.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Ronco, P. McCullough, S. D. Anker, I. Anand, N. Aspromonte, S. M. Bagshaw, R. Bellomo, T. Berl, I. Bobek, D. N. Cruz, et al.
Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative
Eur. Heart J.,
March 2, 2010;
31(6):
703 - 711.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Felker, P. S. Pang, K. F. Adams, J. G. F. Cleland, G. Cotter, K. Dickstein, G. S. Filippatos, G. C. Fonarow, B. H. Greenberg, A. F. Hernandez, et al.
Clinical Trials of Pharmacological Therapies in Acute Heart Failure Syndromes: Lessons Learned and Directions Forward
Circ Heart Fail,
March 1, 2010;
3(2):
314 - 325.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.H. W. Tang and G. S. Francis
The Year in Heart Failure
J. Am. Coll. Cardiol.,
February 16, 2010;
55(7):
688 - 696.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. H. W. Tang and W. Mullens
Cardiorenal syndrome in decompensated heart failure
Heart,
February 1, 2010;
96(4):
255 - 260.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Joles, L. G. Bongartz, C. A. Gaillard, and B. Braam
Renal Venous Congestion and Renal Function in Congestive Heart Failure
J. Am. Coll. Cardiol.,
October 20, 2009;
54(17):
1632 - 1632.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Costanzo and M. Jessup
Reply
J. Am. Coll. Cardiol.,
October 20, 2009;
54(17):
1632 - 1633.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Bart
Treatment of Congestion in Congestive Heart Failure: Ultrafiltration Is the Only Rational Initial Treatment of Volume Overload in Decompensated Heart Failure
Circ Heart Fail,
September 1, 2009;
2(5):
499 - 504.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. T. Shin and G. W. Dec
Ultrafiltration Should Not Replace Diuretics for the Initial Treatment of Acute Decompensated Heart Failure
Circ Heart Fail,
September 1, 2009;
2(5):
505 - 511.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Damman, T. Jaarsma, A. A. Voors, G. Navis, H. L. Hillege, D. J. van Veldhuisen, and on behalf of the COACH investigators
Both in- and out-hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH)
Eur J Heart Fail,
September 1, 2009;
11(9):
847 - 854.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Mullens, G. S. Francis, R. C. Starling, D. O. Taylor, and W.H. W. Tang
Reply
J. Am. Coll. Cardiol.,
August 11, 2009;
54(7):
662 - 662.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Importance of Elevated Venous Pressures in Cardiorenal Syndromes
Journal Watch (General),
April 23, 2009;
2009(423):
4 - 4.
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Jessup and M. R. Costanzo
The Cardiorenal Syndrome: Do We Need a Change of Strategy or a Change of Tactics?
J. Am. Coll. Cardiol.,
February 17, 2009;
53(7):
597 - 599.
[Full Text]
[PDF]
|
 |
|
|